Drugs / Anatriazole
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05885776 | Sep 2022 → Mar 2024 | breast cancer | Tianjin Medical University Cancer Institute and Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anatriazole | “Anatriazole (1mg po qd)” NCT05885776 ↗ |
| Route | Oral | “Anatriazole (1mg po qd)” NCT05885776 ↗ |